US · guidance
CMS Pub. 100-18, ch. 6, § 30.1.2
Conflict of Interest
P&T committee members should sign a conflict of interest statement revealing economic or
other relationships with entities affected by drug coverage decisions that could influence
committee decisions.
History
(Rev. 2, Issued: 07-18-08; Effective/Implementation Date: 07-18-08)
Provenance
- Source
- cms.gov
- Retrieved
- 2026-09-17
- Edition
- iom-2026-09-17
- Content hash
80bf2752cdafe6e60652c27756eaa00132bbfdc7b0314cfcd602f412a55d42ad
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.